NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

We haven't seen any dilution in the past few years. I don't care if we are borrowing at high interest rates. We are an OTC biotech stock while rates have never been higher. That's a cost of doing business. If we need to borrow more I don't think that will be a problem given our Landmark Trial Results. We are easily a $100 stock on global approval for newly-diagnosed and recurrent GBM. That's a cure for cancer which many will pay huge multiples for given our potential for all solid tumors.


https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://pubmed.ncbi.nlm.nih.gov/37129737/

http://nwbio.com/wp-content/uploads/NWBT-GBM-Summit-slides-3-15-23.pdf

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169815671